SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biostruggle who wrote (3582)11/15/2002 3:21:40 PM
From: Icebrg  Read Replies (1) of 10345
 
Yes, they are backing away from doing any further development within the format of their J/V. But that is actually the way most non-Elan joint drug development programs are managed and financed. (Someone pays someone else to do the job and if the development is successful the two parties share the spoils according to some pre-defined formula).

But it doesn't say anywhere, that they are backing away from the development of the drug. If you compare this release with those where they (or rather their partner) say Elan has decided not to support any further development, you will notice the differences.

At least I think I do.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News